Cartilago
Maglie
About Cartilago
Cartilago develops disease-modifying, chondroprotective technologies for combating osteoarthritis and related pathologies. They directly target the pathophysiology of the disease to provide not only symptomatic relief but also to impede the disease's regular natural development. Additional indications are being addressed by the adaptation of their technology, such as anti-aging treatments, wound care, and cancer anti-metastatic therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $255.1K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2020)
- Website: cartilago.it
Industries & Categories
Health Care, Life Science, Medical
Canonical: https://fsome.com/organization/cartilago-193565 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.